What You Should Know:
– eClinical Solutions LLC, a provider of digital clinical software and services, announced that it has received a majority investment from GI Partners, a private investment firm.
– This investment highlights eClinical Solutions’ strong position as a trusted partner for life science organizations of all sizes seeking to accelerate research and advance therapeutic breakthroughs in an increasingly complex trial landscape.
GI Partners’ Commitment to Industry Leaders
This investment reflects GI Partners’ continued dedication to supporting industry leaders in critical services sectors. eClinical Solutions’ elluminate Clinical Data Cloud® SaaS platform streamlines data flows, accelerates cycle times, and boosts productivity, future-proofing clinical trials for clients. The financial terms of the private transaction remain confidential.
eClinical Solutions: A Leader in Clinical Data Solutions
Founded in 2012 in the Boston metropolitan area, a major hub for pharma and biotech innovation, eClinical Solutions has consistently developed technology to address the market’s escalating clinical data challenges. The company is recognized as a leader in data infrastructure and analytics, working with 16 of the Top 50 biopharmaceutical companies to help them derive maximum value from their data using modern infrastructure.
Continued Support from Summit Partners and Founders
Summit Partners, an investor in eClinical since 2020, will retain a minority stake in the company. Additionally, eClinical’s founders will maintain a significant equity position alongside GI Partners.
“When we founded eClinical over a decade ago, clinical data volume and complexity were beginning to escalate rapidly. To improve trial efficiency and help pharmaceutical companies keep up with the mounting pressure to shorten timelines, we had a vision to create frictionless data flows enabled by cloud and digital platforms,” said Raj Indupuri, co-founder and CEO of eClinical Solutions, who will continue to lead the company along with the current management team. “A lot has changed over the years, but our mission hasn’t. We are helping our clients get treatments to patients faster by providing them with a data infrastructure and analytics foundation that powers critical efficiencies across the R&D lifecycle. GI’s support will help fuel the next phase of our company’s journey, as we look to deepen our product roadmap, extend embedded AI capabilities, and help drive future-ready trials.”
